Skip to main navigation
Skip to search
Skip to main content
Sort by
INIS
patients
100%
drugs
44%
storage
36%
wastes
36%
comparative evaluations
18%
carcinomas
18%
particles
18%
spectra
18%
surveys
18%
populations
18%
metastases
18%
tumor necrosis factor
18%
concentration
18%
genetics
18%
kidneys
18%
recommendations
18%
bone joints
18%
compliance
18%
united kingdom
18%
range
17%
size
14%
control
14%
c-reactive protein
12%
data
12%
levels
11%
freezing
11%
communities
10%
diseases
8%
nanoparticles
7%
chromatography
7%
high pressure
7%
ultraviolet radiation
7%
spectroscopy
7%
dynamics
7%
light scattering
7%
validation
6%
supply
6%
chains
6%
pharmaceuticals
5%
implementation
5%
toxicity
5%
plasma
5%
peaks
5%
Medicine and Dentistry
Etanercept
22%
TNF Inhibitor
18%
Prescription Drug
18%
Clear Cell
18%
Genetic Polymorphism
18%
Overall Survival
18%
Sunitinib
18%
Kidney Metastasis
18%
Biosimilar
18%
CTLA-4
18%
Cohort Analysis
18%
Patient Compliance
18%
C Reactive Protein
10%
Hyperbarism
9%
Size-Exclusion Chromatography
9%
Ultraviolet Spectroscopy
9%
Flow Imaging
9%
Photon Correlation Spectroscopy
9%
Nanoparticle
9%
Community Pharmacy
6%
Cross Sectional Study
6%
Single Nucleotide Polymorphism
5%
Programmed Death-Ligand 1
5%
Meta-Analysis
5%
DAS28
5%
Keyphrases
Etanercept
18%
Patient Characteristics
18%
Biosimilar
18%
Ropivacaine
18%
Redispensing
18%
Medication Factor
18%
Total Knee Arthroplasty
18%
Tourniquet Use
18%
Pharmacokinetics
18%
Medication Wastage
18%
Drug Storage
18%
C-reactive Protein
11%
Historical Cohort
9%
Local Infiltration Analgesia
9%
Tourniquet
9%
95% Confidence Interval
9%
Community Pharmacy
7%
Treatment Persistence
5%
Persistence Rate
5%
Disease Activity Score 28 (DAS28)
5%
Dutch
5%
Unused Medicines
5%